Spravato

Active Ingredient(s): Esketamine Hydrochloride
FDA Approved: * March 5, 2019
Pharm Company: * JANSSEN PHARMS
Category: Antidepressant

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Spravato Overview

Esketamine, sold under the brand name Spravato[6] among others,[8][9] is a medication used as a general anesthetic and for treatment-resistant depression.[6][3] Esketamine is used as a nasal spray or by injection into a vein.[6][3] Esketamine acts primarily as a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist.[3][10] It also acts to so...

Read more Spravato Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Esketamine

Recent Spravato Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Esketamine Hydrochloride
  • Injection: 100mg/ml, 10mg/ml, 50mg/ml
  • Spray: 28mg, 84mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Spravato: (1 result)

Sorted by National Drug Code
  • 50458-028 Spravato 28 mg/.2ml Nasal Solution by Janssen Pharmaceuticals Inc.

Other drugs which contain Esketamine Hydrochloride or a similar ingredient: (3 results)